Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists | HTML
Structure–Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin | Journal of Medicinal Chemistry
Kappa‐Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials - Carlezon - 2016 - Depression and Anxiety - Wiley Online Library
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
IJMS | Free Full-Text | The Mechanisms Involved in Morphine Addiction: An Overview | HTML
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Development of κ Opioid Receptor Antagonists | Journal of Medicinal Chemistry
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140) | Journal of Medicinal Chemistry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Structure–Activity Relationship Studies of Functionally Selective Kappa Opioid Receptor Agonists that Modulate ERK 1/2 Phosphorylation While Preserving G Protein Over βArrestin2 Signaling Bias | ACS Chemical Neuroscience
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140) | Journal of Medicinal Chemistry
Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action | PNAS
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140) | Journal of Medicinal Chemistry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
Opioids in cancer: The κ‑opioid receptor (Review)
Structure–Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin | Journal of Medicinal Chemistry
Role of kappa-opioid receptors in stress and anxiety-related behavior. - Abstract - Europe PMC
Kinase cascades and ligand-directed signaling at the kappa opioid receptor. - Abstract - Europe PMC
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion - ScienceDirect
Role of kappa-opioid receptors in stress and anxiety-related behavior. - Abstract - Europe PMC
Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140) | Journal of Medicinal Chemistry
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives | SpringerLink
